Dhathri Ayurveda Hospitals And Researches Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-06-2024
- Paid Up Capital ₹ 0.10 M
as on 28-06-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Profit -64.99%
(FY 2020)
- Ebitda -64.99%
(FY 2020)
- Net Worth -44.31%
(FY 2020)
- Total Assets -100.00%
(FY 2020)
About Dhathri Ayurveda Hospitals And Researches
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saji Nair and Rajalekshmy Nair serve as directors at the Company.
- CIN/LLPIN
U85110KL2010PTC026632
- Company No.
026632
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dhathri Ayurveda Hospitals And Researches?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saji Nair  | Director | 30-Aug-2010 | Current |
| Rajalekshmy Nair | Director | 30-Aug-2010 | Current |
Financial Performance of Dhathri Ayurveda Hospitals And Researches.
Dhathri Ayurveda Hospitals And Researches Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 64.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 44.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhathri Ayurveda Hospitals And Researches?
In 2020, Dhathri Ayurveda Hospitals And Researches had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Soukhym Ayurveda And Natural Products Private LimitedActive 12 years 3 months
Saji Nair is a mutual person
- Dhathri Bio-Sciences Private LimitedActive 3 years 4 months
Saji Nair and Rajalekshmy Nair are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dhathri Ayurveda Hospitals And Researches?
Unlock and access historical data on people associated with Dhathri Ayurveda Hospitals And Researches, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhathri Ayurveda Hospitals And Researches, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhathri Ayurveda Hospitals And Researches's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
